EPHEPRES Trademark

Trademark Overview

On Sunday, July 19, 2020, a trademark application was filed for EPHEPRES with the United States Patent and Trademark Office. The USPTO has given the EPHEPRES trademark a serial number of 90060776. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 14, 2023. This trademark is owned by Eton Pharmaceuticals, Inc.. The EPHEPRES trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treatment of hypotension; Pharmaceutical compositions for treatment of hypotension; Pharmaceutical formulations for treatment of hypotension in the setting of anesthesia; Pharmaceutical formulations containing ephedrine for treatment of clinically important hypotension in the setting of anesthesia; Pharmaceutical formulations for treatment of hypotension
ephepres

General Information

Serial Number90060776
Word MarkEPHEPRES
Filing DateSunday, July 19, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 14, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 17, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for treatment of hypotension; Pharmaceutical compositions for treatment of hypotension; Pharmaceutical formulations for treatment of hypotension in the setting of anesthesia; Pharmaceutical formulations containing ephedrine for treatment of clinically important hypotension in the setting of anesthesia; Pharmaceutical formulations for treatment of hypotension

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 14, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEton Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDeer Park, IL 60010
Party NameEton Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDeer Park, IL 60010

Trademark Events

Event DateEvent Description
Monday, August 14, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 14, 2023ABANDONMENT - NO USE STATEMENT FILED
Saturday, January 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 12, 2023SOU EXTENSION 4 GRANTED
Thursday, January 12, 2023SOU EXTENSION 4 FILED
Thursday, January 12, 2023SOU TEAS EXTENSION RECEIVED
Thursday, July 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 12, 2022SOU EXTENSION 3 GRANTED
Tuesday, July 12, 2022SOU EXTENSION 3 FILED
Tuesday, July 12, 2022SOU TEAS EXTENSION RECEIVED
Monday, March 7, 2022ASSIGNED TO EXAMINER
Thursday, January 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 11, 2022SOU EXTENSION 2 GRANTED
Tuesday, January 11, 2022SOU EXTENSION 2 FILED
Tuesday, January 11, 2022SOU TEAS EXTENSION RECEIVED
Saturday, June 26, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 24, 2021SOU EXTENSION 1 GRANTED
Thursday, June 24, 2021SOU EXTENSION 1 FILED
Thursday, June 24, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, January 12, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 17, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 17, 2020PUBLISHED FOR OPPOSITION
Wednesday, October 28, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, October 5, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 2, 2020EXAMINER'S AMENDMENT ENTERED
Friday, October 2, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, October 2, 2020EXAMINERS AMENDMENT E-MAILED
Friday, October 2, 2020EXAMINERS AMENDMENT -WRITTEN
Friday, October 2, 2020ASSIGNED TO EXAMINER
Friday, August 14, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 22, 2020NEW APPLICATION ENTERED

Related Keywords

ephepres treatment pharmaceutical hypotension formulations setting anesthesia clinically important ephedrine containing